Literature DB >> 31102566

Serum prealbumin is a prognostic indicator in idiopathic pulmonary fibrosis.

Biyun Li1, Xinran Zhang2, Guodong Xu2, Shu Zhang3, Huifang Song4, Kaiyuan Yang5, Huaping Dai1,6, Chen Wang1,6.   

Abstract

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by variable progression. The prealbumin (PA) is a parameter in a routine blood biochemistry examination. We sought to investigate the prognostic value in IPF patients.
OBJECTIVES: To evaluate the prognosis value in patients with IPF.
METHODS: Blood biochemistry examination, demographics, pulmonary function data from patients with IPF consulted in Beijing Chao-Yang Hospital and China-Japan Friendship Hospital between July 2012 and December 2016 were collected. Infection, liver and kidney dysfunction and lung transplantation are excluded from the cohort.
RESULTS: The result of multivariate Cox analysis showed that PA was significant prognostic indicator of survival along with BMI, FVC, serum albumin protein and serum global protein. The patients with PA concentration <0.2 mg/L had shorter survival compared with those whose PA were normal. Although the survival had no significant difference between the patients with PA concentration < 0.2 mg/L and albumin < 35 g/L and those with PA concentration < 0.2 mg/L, the average survival time of patients with PA concentration < 0.2 mg/L and albumin < 35 g/L were shorter.
CONCLUSIONS: Our study indicated that IPF patients with PA concentration < 0.2 mg/L have poorer outcome. Further studies are warranted to indentify PA as a predictor for IPF patients outcomes and explore the role of PA in the pathogenesis of IPF.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  idiopathic interstitial pulmonary; prealbumin; prognosis; survival time

Mesh:

Substances:

Year:  2019        PMID: 31102566     DOI: 10.1111/crj.13050

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  3 in total

1.  Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.

Authors:  Ryota Kikuchi; Hiroyuki Takoi; Takao Tsuji; Yoko Nagatomo; Akane Tanaka; Hayato Kinoshita; Mariko Ono; Mayuko Ishiwari; Kazutoshi Toriyama; Yuta Kono; Yuki Togashi; Kazuhiro Yamaguchi; Akinobu Yoshimura; Shinji Abe
Journal:  Thorac Cancer       Date:  2021-01-21       Impact factor: 3.500

Review 2.  Perioperative Management of Patients with Idiopathic Pulmonary Fibrosis Undergoing Noncardiac Surgery: A Narrative Review.

Authors:  Zyad J Carr; Luying Yan; Jose Chavez-Duarte; Jill Zafar; Adriana Oprea
Journal:  Int J Gen Med       Date:  2022-02-23

3.  Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.

Authors:  Ryota Kikuchi; Hiroyuki Takoi; Takao Tsuji; Yoko Nagatomo; Akane Tanaka; Hayato Kinoshita; Mariko Ono; Mayuko Ishiwari; Kazutoshi Toriyama; Yuta Kono; Yuki Togashi; Kazuhiro Yamaguchi; Akinobu Yoshimura; Shinji Abe
Journal:  Thorac Cancer       Date:  2021-05-03       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.